Search Results 571-580 of 16986 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A recent Mayo Clinic retrospective study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined ...
Overview · High-throughput systems to identify cell-targeting ligands to target drugs, diagnostics, vaccines and gene delivery vectors. · Developing genetic and ...
Radioactive substances linked to monoclonal antibodies can bind to cancer cells and give off radiation which may help kill cancer cells. It is not yet known ...
About this study. Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease.
About this study. The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic ...
This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), ...
Access to care. Analysis of secondary data. Artificial intelligence. Biostatistics. Economic and health technology evaluations. Evaluation of clinical practice ...
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.